Table 5.
Effectiveness of our method regarding to the segmentation drawbacks.
| Segmentation drawbacks | Test number | Dice (%) | |
|---|---|---|---|
| Baseline | Channel-UNet | ||
| Stomach | 20 | 94.25 | 97.65 (+3.40) |
| Pancreas | 15 | 95.55 | 97.62 (+2.07) |
| Duodenum | 19 | 95.35 | 97.42 (+2.07) |
| Metal | 3 | 96.90 | 98.15 (+1.25) |
| Heart | 4 | 96.74 | 97.97 (+1.23) |
| Diaphragm | 5 | 96.54 | 97.76 (+1.22) |
| Spleen | 7 | 90.82 | 94.43 (+3.91) |
| Colon | 9 | 96.65 | 98.64 (+1.99) |
| Muscles | 16 | 93.16 | 96.07 (+2.91) |
| Esophagus | 18 | 93.77 | 96.81 (+3.40) |
| No | 12 | 97.85 | 98.86 (+1.01) |
Baseline is the UNet with data augmentation.